12:00 AM
 | 
Sep 08, 2008
 |  BC Week In Review  |  Company News  |  Deals

Pain Therapeutics Inc., King deal

Pain Therapeutics received two milestone payments from King totaling $20 million under a 2005 agreement to develop and commercialize Pain’s abuse-resistant opioid painkillers. A $15 million payment was triggered by FDA accepting for filing an...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >